| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Kite Pharma
|
Yes | Post-IPO Equity |
CAM Capital
|
Yes | Series C |
Aju IB Investment
|
Yes | Series B |
Quan Capital
|
Yes | Series B |
Adage Capital Management
|
- | Series C |
Asymmetry Ventures
|
- | Series C |
CaaS Capital Management
|
- | Series C |
Cambrian Biopharma
|
- | Series C |
Clough Capital Partners
|
- | Series C |
|
|
- | Series C |
JVC Investment Partners
|
- | Series B |
Mirae Asset Capital
|
- | Series B |
Mirae Asset Venture Investment
|
- | Series B |
New Enterprise Associates
|
- | Series B |
Novo Holdings
|
- | Series B |
Solasta Ventures
|
- | Series B |
SR One
|
- | Series B |
Takeda Ventures
|
- | Series B |
Novo Ventures
|
- | Series A |